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Abstract
Background: There is some evidence that people with intellectual disabilities who live in the community are
exposed to the same risks of alcohol use as the rest of the population. Various interventions have been evaluated in
the general population to tackle hazardous or harmful drinking and alcohol dependence, but the literature
evaluating interventions is very limited regarding intellectual disabilities. The National Institute for Health and
Clinical Excellence recommends that brief and extended brief interventions be used to help young persons and
adults who have screened as positive for hazardous and harmful drinking. The objective of this trial is to investigate
the feasibility of adapting and delivering an extended brief intervention (EBI) to persons with mild/moderate
intellectual disability who live in the community and whose level of drinking is harmful or hazardous.
Methods/Design: The study has three stages, which include the adaptation of the Extended Brief Intervention (EBI)
for people with intellectual disability, a single blind, randomised controlled trial of an individual Extended Brief
Intervention to test the feasibility of the intervention, and a qualitative study that will assess the perceived
acceptability and usefulness of the intervention. Fifty participants in total will be recruited from community
intellectual disability services and social care or third sector organisations. The main outcome is a reduction in
alcohol consumption measured by the Alcohol Use Disorders Identification Test.
Discussion: Alcohol misuse is a relatively under-researched mental health problem in people with intellectual
disabilities. Therefore, the study addresses both diagnostic issues and the delivery of a simple first stage intervention,
which is available to the population of average intelligence and young persons in particular. The findings from the
study will guide the preparation of a large-scale study to test whether this treatment is clinically and cost-effective in
this population.
Trial registration: ISRCTN58783633 (19 December 2013).
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Alcohol is the most commonly used substance worldwide
and contributes substantially to mortality, psychiatric and
physical health morbidity and causes increased disease
burden [1,2]. Despite the sparse literature regarding sub-
stance misuse in people with intellectual disabilities (char-
acterised by an Intelligence Quotient (IQ) less than 70,
developmental delay and adaptive deficits), there is in-
creasing interest in studying such problems in this popula-
tion. This is because most now live in the community and
are more likely to be exposed to substances [3,4]. United
Kingdom and United States population-based studies indi-
cate that the prevalence of substance misuse in people
with intellectual disabilities ranges from 0.5% and 2.5%,
respectively, to as high as 25% for any substance in clinic
samples [4-6]. Approximately 5% of the youth in drug and
alcohol services have a degree of intellectual disability [1].
The most common substance that people with intellectual
disabilities tend to use is alcohol, followed by cannabis
and cocaine [2]. Aetiological factors that have been postu-
lated to contribute to substance misuse in people with
mild to moderate intellectual disabilities include hyper-
activity, lack of assertiveness, low self-esteem, susceptibil-
ity to peer pressure, desire for social acceptance, social
isolation, early onset of drinking and lack of example set-
ting in childhood [1]. Substances may also be taken as a
maladaptive way of relieving stress or developing relation-
ships within local communities [7,8]. Those most at risk
are young males with a mild intellectual disability or bor-
derline intelligence who live independently and are less
likely to engage in activities and/or to experience mental
health problems [1].
Brief and extended brief interventions have been eval-
uated in the general population to tackle hazardous or
harmful drinking and alcohol dependence. Despite the
heterogeneity observed in the studies, a meta-analysis
showed that participants generally have lower alcohol
consumption at one year (mean difference: -38 grams/
week, 95% CI: -54 to -23 and mean difference = -28, 95%
CI: -62 to 6 grams/week, for brief and extended brief
interventions, respectively) [9]. The same meta-analysis
reports that loss to follow-up ranges from 10% to 70%
but only three studies reported such rates. However,
the literature evaluating any interventions targeted at
people with intellectual disabilities is uncommon. This
is partly due to the general lack of evidence based in-
terventions in this field, but also to the belief that in-
terventions that are suitable for typically functioning
adolescents and adults are also suitable for those with
mild-moderate intellectual disabilities without need for
adaptation. This seems counterintuitive as people with
intellectual disabilities have cognitive deficits that im-
pair their ability to learn or generalise new learning,
and therefore may require interventions to last longer,
to include maintenance sessions, and to be supported
to seek help and attend appointments. It is often re-
ported that staff delivering interventions to the general
population may not be skilled to provide such treat-
ment to people with intellectual disabilities [8].
A variety of approaches have been tried to help people
with mild to moderate intellectual disabilities and sub-
stance misuse, including education about the risks asso-
ciated with substance misuse, behavioural modification,
and the use of adapted materials from Alcoholics An-
onymous or similar organisations, mostly delivered in
group settings [10-16]. As a whole, these studies suggest
that the capacity of people with intellectual disabilities
to learn new information is enhanced by providing add-
itional cues and using techniques such as modelling,
videotaped vignettes and role-playing [15]. Often, ses-
sions are augmented with coping skills lessons and
assertiveness training [17]. However, the studies con-
ducted to date are small, run in specialist single centre
settings and are uncontrolled.
Nevertheless, two studies merit further attention; one
is a study of three sessions of group motivational inter-
viewing over two weeks conducted with seven offenders
with intellectual disabilities in a medium secure unit
[18]. The authors found that the participants showed
increased determination to reduce drinking at the end of
the treatment. The second study [15], was a 10-week
evaluation of assertiveness training and modelling to
educate about substance misuse and to help the partici-
pants (N = 84) to respond appropriately when offered
substances in their social network. The authors found
that knowledge of the risks associated with use of
illicit substances increased at the end of the intervention,
and this was maintained at six- months follow-up. The
methodological limitations of the studies include the
uncontrolled design, the small sample size, insufficient
details of reporting, inclusion of several types of sub-
stances in the educational materials and the delivery in a
specific environment that is different from community
living.
The National Institute for Health and Clinical Excel-
lence (NICE) (PH24; [19]) recommends that brief and ex-
tended brief interventions are used to help young persons
and adults who have screened positive for hazardous and
harmful drinking. The interventions recommended are
based on motivational interviewing/enhancement tech-
niques, and are delivered by trained professionals. Their
aim is to reduce alcohol intake, reduce risk-taking behav-
iour and even to consider abstinence. The sessions are
short at 30 minutes and follow-up is offered. At all times,
individuals who are referred for treatment have their
capacity to consent to it assessed and, where further treat-
ment is indicated, referrals to secondary specialist services
should be made.
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(EBI) in the current study because it is a widely used
and evaluated treatment in the literature for hazardous
and harmful drinking. It is a low-intensity intervention
and can be delivered by trained professionals in the pub-
lic and voluntary sector.
Aims and objectives
The key research question is: Can we design a large
scale, randomised controlled trial (RCT) that will answer
whether EBI is more effective than usual care in helping
adults with mild to moderate intellectual disability to
reduce their alcohol intake?
The feasibility trial will compare the use of EBI with
treatment as usual in the participating areas and will
enable us do the following:
1. measure the number of eligible participants,
including paid and family carers, willingness of
clinicians to recruit participants, recruitment rate,
loss to follow-up, adherence to the intervention, and
standard deviation of the primary outcome
measures. This will ultimately inform the sample-
size calculation for a multicentre clinical trial.
2. determine the acceptability of randomisation to
service users through its effect on dropout rates and
qualitative interviews.
3. determine, through response rates to
questionnaires, the appropriateness and the
acceptability of the outcome measures to service
users and their carers in order to explore the
suitability of our chosen secondary outcome
measures, that is, days abstinent, service use and
health-related quality of life.
4. estimate the time needed to collect and analyse data
5. explore the utility of the health-related quality of life
questionnaire in allowing the estimation of quality-
adjusted life years in the sample.
We will also conduct qualitative interviews with ser-
vice users, their carers, and service providers, to assess
the acceptability of the treatment and to explore their
experience of the treatment including any barriers and/
or facilitators to taking part in the study. Findings from
these interviews will enable us to refine the EBI.
Methods/Design
The study corresponds to Phase 2 of the Medical Re-
search Council (MRC) complex interventions guidelines,
which guides the development of an intervention [20].
Therefore, the study has three stages that will be dis-
cussed below.
Stage 1-Adaptation of the intervention
We will review the literature on EBI, and we will consult
with service users and professionals about the number
of sessions to be delivered and the materials to be used
in each session. This is particularly important as people
with intellectual disabilities have substantial cognitive
deficits that require a longer duration of treatment, a
mixture of materials, and the opportunity to test skills
learnt over time [21]. So while the adapted intervention
will include the existing treatment, such as a detailed
assessment of drinking behaviour and the development
of coping plans, it will be also include strategies to make
engaging with the intervention easier, such as repetition
of information and longer sessions.
The treatment manual will be tested with three service
users (see Inclusion criteria below) in terms of accept-
ability and clarity, and the intervention will be refined
accordingly. A similar approach has been used in a pre-
vious study [22]. The data from these individuals will
not be included in the final analysis of the results.
Stage 2-Feasibility study
Design
This will be a single blind, randomised controlled trial of
individual EBI delivered as an adjunct to usual care for
alcohol use disorders (AUD). Fifty participants, rando-
mised to either the intervention arm or usual care, will
be assessed at baseline, two months and three months.
Research assistants carrying out assessments will be
blind to the trial arm to which the participants are
allocated.
Finally, qualitative interviews will be carried out at
three months (see stage 3 below).
Setting
The study will be conducted within the Community
Intellectual Disabilities Teams and social care services
in three participating areas in England, UK, including
urban and inner city locations. These teams offer spe-
cialist mental health, social care support and health
services to adults with intellectual disability, as well as
residential and supported living accommodation.
Participants
Fifty adults with mild to moderate intellectual disabilities
aged 18 years and over, and who are known to profes-
sionals within the intellectual disabilities services as pos-
sibly having an alcohol problem, will be eligible to be
referred to the study. Each participant should have a
carer or family member prepared to accompany them to
their sessions and complete the study instruments. Fur-
ther justification for the sample size is available from
http://www.nihr.ac.uk/CCF/RfPB/FAQs/Feasibility_and_-
pilot_studies.pdf.
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assessed with the Wechsler Abbreviated Scale for
Intelligence (WASI) [23] to ascertain their level of cogni-
tive functioning (unless results from a previous cognitive
assessment are available).
Recruitment
Recruitment of participants will be achieved through con-
tacts and liaison with the intellectual disability services in
the participating areas. Supported accommodation and
social clubs in those areas will also be approached.
Research assistants will work to increase publicity of the
study by presenting it at all team meetings and submitting
adverts for the study in organisational newsletters. Partici-
pant flow to the study is shown in Figure 1.
Inclusion criteria
Inclusion criteria are as follows:
1. AUDIT score >8 (providing the sum of questions 4,
5 and 6 is below 9). A score of 8 and above indicates
hazardous or harmful drinking [24]. Questions 4, 5
and 6 specifically assess symptoms of dependence.
The National Institute of Care and Clinical
Excellence (NICE) [19] advises a reduction of scores
in particular populations who may have lower
prevalence of AUD, such as older people, females,
and younger people. Local data, however, suggests
that the prevalence of AUD in adults with mild/
moderate intellectual disability in contact with
services based on an AUDIT cut off of 8 is 22.5%,
which is similar to the prevalence in the general
population [4]. Therefore, a decision was made to
adopt the same cut-off AUDIT score as in the
general population.
2. Residents in the area within the last 12 months.
3. Full Scale IQ <70 (+/− 5% CI), which is the range
for mild and moderate intellectual ability.
Exclusion criteria
Exclusion criteria are as follows:
1. severe to profound intellectual disabilities.
2. non-English speaking requiring interpreters.
Figure 1 Recruitment flow diagram.
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in the last 12 months.
4. acute stage of severe and enduring mental illness.
5. poly-substance misuse including alcohol where the
illicit substance, for example, cocaine/heroin/
cannabis is the main problem.
Trial arms
The trial arms are as follows:
1. Intervention: EBI is modified as described in stage
1. It will be provided over five half-hour weekly
sessions with a final one-hour session after eight
weeks. It will be delivered by a trained therapist
recruited from the NHS/private or third sector
providing alcohol services in England. It is likely
that the therapist may not have experience working
with adults with intellectual disabilities; therefore, the
research team members will provide training in the
form of a one-day induction, including aspects of
communication and how to overcome cognitive
limitations in people with intellectual disabilities,
interviewing techniques, use of the manualised
treatment and guided reading to enhance clinical
skills in working with this population. Furthermore,
tapes of early treatment sessions will be reviewed
by co-authors CK and KS. The therapist will be
supervised regularly by CK, a consultant psychiatrist
in addictions and trained in motivational interviewing.
2. Treatment as usual: Service users with mild to
moderate intellectual disabilities who are identified
as having AUD usually receive little specific support
[25]; however, if problems escalate to dependence,
they may be referred and managed jointly with
secondary substance misuse services. Therefore, they
may be offered non-specific counselling on improving
coping abilities, pharmacological interventions where
there are comorbid mental health problems or to
achieve abstinence, inpatient admission if required,
encouragement to attend community services for
alcohol disorders, social support and nursing input if
they experience any physical signs of malnutrition or
epilepsy and other alcohol-related morbidity.
Outcome measures
The primary outcome is a reduction in alcohol intake
measured by the modified Alcohol Use Disorders Identifi-
cation Test (AUDIT) [24]. As there is limited experience
of suitable measures for interventions for substance mis-
use in this population, the percentage of days of abstin-
ence (PDAS) and percentage of days of heavy drinking
(PDHD) will also be calculated. Definition of heavy drink-
ing will be informed by a literature review [26]. These
additional indices have been included in order to estimate
which outcome may perform most reliably for a sample
calculation for a definitive trial.
Secondary outcomes will be willingness to change,
health status, service use, health-related quality of life
and mental status.
Instruments
Instruments used in the trial will include the following:
1. AUDIT [24], which is a screening tool for
identification of excessive drinking, an aid to brief
interventions, and it has been used with people with
mild to moderate intellectual disabilities. It will be
administered at all treatment points.
2. Readiness to Change Questionnaire (RCQ) [27],
which has been shown to have good validity and
reliability. It contains 12 statements that must be
read to the person with mild to moderate
intellectual disabilities. It will be administered at
baseline and three months.
3. Euro-QoL (EQ-5D-3 L); English version [28],
which is a short questionnaire assessing general
healthcare. This questionnaire has been used
extensively in health research in the general
population and more recently in studies of
populations with intellectual disabilities. This will
be administered at baseline and three months.
4. Clinical Outcomes in Routine Evaluation (CORE-LD)
[29], which is an adapted version of the instrument
for people with intellectual disabilities and measures
self-reported psychological distress. It will be
administered at baseline and three months.
5. Client Service Receipt Inventory (CSRI) [30],
which is specifically adapted for the study to
measure what services the client has been in
receipt of in the past 6 months (for example,
emergency room attendance, GP visits, benefits).
It will be completed at baseline and three months
for the previous three months. Data gathered by
this tool will allow us to be more precise in
recording the different services received by
participants each study arm beyond the
intervention and quantify the elements of
‘treatment as usual’.
6. Sociodemographic details at baseline.
All instruments will be completed by research assis-
tants in face-to-face assessments with participants and
paid or family carers. These assessments will take place
at a convenient location. AH and KS will train Research
assistants in interviewing techniques for people with
intellectual disabilities, how to assess capacity to consent
to research and how to administer the study instruments.
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Randomisation will be conducted by contacting an ex-
ternal researcher once the potential participant has con-
sented to take part in the study and baseline data have
been collected (class A method of randomisation). The
research team statistician will generate the randomisa-
tion list. Any breach in blinding/unmasking, a common
problem with single blind trials, will be monitored to
ensure that the research assistants are not aware, as far
as possible, to which group the individual was allocated.
The researchers will make a note of which group he/she
believes the participant has been allocated to for all par-
ticipants and this will be compared to the actual alloca-
tions at the end of the study. The database management
will be supervised by the PRIMENT Clinical Trials Unit
and the study statistician GB.
Treatment fidelity
We will develop a short scale to measure how the treat-
ment is delivered and which components are used in
each session, guided by the literature [31]. Ten per cent
of the audiotaped sessions will be rated by KS, who has
no contact with the therapist. The therapist will be su-
pervised regularly throughout the study duration by CK.
Statistical analysis
The analysis of the data will be mainly in terms of
descriptive statistics and point and interval estimations
with the express aim to inform a future multicentre trial.
No hypothesis testing will be performed. We will com-
pare drop-out rates in the intervention and treatment-
as-usual arm, and means, medians, interquartile ranges,
counts and proportions to estimate effect size will be
calculated. Regression models allowing for participant
clustering will be considered to examine the association
between the primary outcome and sociodemographic
and clinical predictors. The results will be presented
with 95% confidence intervals.
Economic evaluation and analysis
The feasibility of collecting information for a full rando-
mised control trial (RCT) cost-effectiveness analysis will
be assessed, based on cost per gain in outcome of EBI
compared to treatment as usual from a health and social
care cost perspective. Costs will include the intervention,
training and health and social care provision. Health and
social care resource use, employment and the impact on
carers will be costed using national published values.
The feasibility of a cost-effectiveness analysis from a
societal cost perspective will also be assessed. Descrip-
tive statistics for these variables will be reported and an
initial analysis will calculate 1) the mean incremental
cost per reduction in days of heavy drinking and 2) the
mean cost per quality adjusted life year (QALY) gained
using the EQ-5D mapping algorithm. Previous studies in
the general population have found that generic quality of
life measures are not sensitive to reductions in alcohol
misuse, particularly in hazardous drinkers [32]. We will
test whether this is also the pattern in adults with mild
to moderate intellectual disabilities and whether we can
use these measures in a full trial using correlations,
regression analysis and mapping. Some of the impact
from long-term hazardous and harmful alcohol misuse
can occur well into the future. Due to the short follow-
up period, it is unlikely that the long-term impact will
be captured within this trial, but this will require further
investigation as part of a full trial using decision analyt-
ical models.
Stage 3-Qualitative study
In order to assess the perceived acceptability and useful-
ness of the intervention, 50% of service user and carer
dyads allocated to the EBI arm of the trial, will be inter-
viewed at end of treatment (that is, 12 weeks). The inter-
views will be completed by the two service users who
are supported to contribute to the study reference group
(part of the trial management group), with support from
the research assistants. Both service users and the
research assistants will be trained in how to collect
qualitative data and conduct the interviews. We will
include participants who may have dropped out of treat-
ment, if at all possible, in order to ascertain their percep-
tions of the intervention and their reasons for dropping
out. Interviews will be audiotaped and analysed using
content analysis and/ or thematic analysis [33,34].
Ethical and research and development reviews
The study has been approved by the NRES Committee
South Central - Berkshire (REC reference 13/SC/0143).
All study personnel will comply with the MCA 2005
[35] and published research governance guidelines. We
anticipate that all participants will have capacity to con-
sent and sufficient verbal communication skills to take
part in the treatment and in the qualitative interview.
All patient information sheets and consent forms will be
in easy-read versions, and informed written consent will
be obtained from all participants. As this is a non-
invasive intervention, we do not anticipate any adverse
events, but we will follow safety reporting guidance
issued by the National Research Ethics Service (UK) for
studies except clinical trials of investigational medicinal
products.
The study has been approved by the Research and
Development departments of the following organisa-
tions: Hertfordshire Partnership NHS Foundation Uni-
versity Trust, Camden and Islington NHS Foundation
Trust, Surrey and Borders Partnership NHS Foundation
Trust.
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We consulted with a service user group based in one of
the research areas on two different designs for the study,
one being the current version and the other a feasibility
study of contingency management. The latter is defined
as treatment based on principles of behaviour modifica-
tion and aims to incentivise and then reinforce changes
in behaviour with the aid of vouchers, privileges, prizes
or modest financial incentives that are of value to the cli-
ent (https://www.nice.org.uk/guidance/cg51/chapter/ap-
pendix-c-contingency-management-key-elements-in-the-
delivery-of-a-programme). Based on the various issues
identified as potential difficulties in each option, we made
the decision to start from a simpler project that has yet
to be tested in this population. An easy-read version of
the project proposal was presented to a service users’
group for advice and comments on how to present the
study and describe the intervention. Two service users
and their carers contribute to the trial steering commit-
tee and will conduct the qualitative interviews as
described earlier. The service users will be involved in
the interpretation of the interviews, write up the findings
in an accessible format and disseminate them locally and
nationally.
Discussion
The study will provide invaluable information on several
aspects of alcohol and other substance misuse patterns
in people with intellectual disability. Although not an
epidemiological study per se, it will reveal important ele-
ments of treatment pathways and support needs for
those individuals. Such information is currently either
not available or mostly derived from clinic populations.
Our sample will be drawn from a wide variety of com-
munity care.
Furthermore, there is limited literature on use of alco-
hol instruments such as AUDIT and RCQ in people with
intellectual disabilities; therefore, the adapted tools used
in this project will be particularly useful for further
research but also in clinical practice in this field.
Most importantly, there is emerging debate about the
impact of brief interventions delivered in primary care
on alcohol problems [36]. Current literature suggests
that they indeed reduce consumption, but there is little
information on the content and fidelity of the interven-
tion in published studies.
In carrying out the study, we will need to overcome
generic difficulties in research in adults with substance
misuse who may be not only be hard to reach but also
unwilling to commit to treatment or may drop out. Ac-
cess to participants may depend on local configurations
of services, and therefore, the recruitment strategy will
be crucial in carrying out the feasibility study. Therefore,
our work will be sufficiently novel to contribute not only
to the field of intellectual disabilities but to the existing
research in this particular topic.
Trial status
At the time of the manuscript submission the trial is still
recruiting new participants.
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